| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-10 |